Work

Phase Ib evaluation of a recombinant overlapping peptide survivin immunotherapy: Safety, immunogenicity, and immune–clinical associations in advanced solid tumours.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2651

Authors: Shisong Jiang, Thomas Morris, Martin David Forster, Fiona Thistlethwaite, Mark H. Tuthill, Anja Williams, William Finch

Institutions: University of Oxford, University College London Hospitals NHS Foundation Trust, University College London, University of Manchester, The Christie NHS Foundation Trust, Oxford University Hospitals NHS Trust, Sarah Cannon Research Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162560786

Cites:

Cited by:

Related to: